KRAS and pancreatic neoplasm: On the other hand, oncogenic KRAS mutations have been shown to be involved in the development of pancreatic cancer from chronic pancreatitis [85,86,87], indicating that enhanced MAPK-ERK signaling is involved in promoting pancreatic cancer progenitor cell expansion and tumorigenesis by stromal cell populations within the inflammatory TME.